July 5 (Reuters) - MEI Pharma Inc :
* MEI PHARMA HIGHLIGHTS RECOMMENDATION BY LEADING INDEPENDENT PROXY ADVISORY FIRM ISS TO VOTE “FOR” PENDING TRANSACTION WITH INFINITY PHARMACEUTICALS
Source text for Eikon: Further company coverage:
((reuters.briefs@thomsonreuters.com;))